GET DAILY SIGNALSGlass House Brands (GLAS) Falls -51% in 30 Days as Wholesale Pricing Weakens
Key Takeaways
- Glass House Brands (GLAS) has fallen roughly 51% over the last 30 days, dropping from about $4.08 to near $2.00 amid sharp margin compression.
- The decline was driven primarily by a collapse in realized wholesale cannabis pricing, which overshadowed record production volumes in preliminary third-quarter results.
- Leadership changes—including a planned CFO retirement and a board resignation—added to investor uncertainty during the period.
- Analysts lowered price targets, with Lake Street cutting its target to $7 from $17 and the broader consensus target revised lower to $9.77.
- Weakness across the broader cannabis sector amplified selling pressure, with the stock trading near its 52-week low.
Glass House Brands (GLAS) Overview and Market Position
Glass House Brands Inc. is a vertically integrated cannabis company headquartered in Long Beach, California. The company cultivates, produces, and distributes wholesale cannabis biomass and consumer packaged goods primarily within California, operating some of the largest greenhouse cultivation facilities in the state in Carpinteria and Camarillo, with production in Lompoc. Its brand portfolio includes Glass House Farms, PLUS, REEFORM, Allswell, and Mama Sue Wellness.
Following the deconsolidation of its retail subsidiary in mid-2026, GLAS now operates more closely as a pure wholesale greenhouse grower, competing on cost per pound of produced biomass. I reviewed the setup using Tickeron’s AI Screener to compare its positioning against peers. Investors follow the stock for its low-cost greenhouse model, its push toward a long-term production cost target of $95 per pound, and its optionality around interstate commerce and international exports as U.S. federal cannabis policy evolves.
GLAS Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, GLAS shares have fallen approximately 51%, declining from a close near $4.08 to recent levels around $2.00. The move accelerated in the second half of October, when the stock experienced several consecutive double-digit daily declines and hit a 52-week low of $1.67 before stabilizing.
The weakness extends well beyond the past month. Over the last quarter, the stock has shed roughly three-quarters of its value, falling from levels near $8 in early September to below $2 in November. For the year to date, GLAS has declined roughly 76%, and the shares now trade far below their 52-week high of $13.93. The consistent theme has been a steady re-rating lower as improving production scale has been outweighed by deteriorating unit economics.
What Drove the Recent 30-Day Move in GLAS
The sharpest catalyst was the company's preliminary, unaudited third-quarter results announced in mid-October. While Glass House reported record biomass production of approximately 317,000 pounds and a further reduction in cost of production to about $110 per pound, the realized average selling price collapsed to $150 per pound from $211 in the second quarter. As a result, gross margin compressed to 26% from 34% sequentially, and the market focused on shrinking gross profit per pound rather than record volume. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how the stock compared to others in the industry.
Leadership uncertainty compounded the pressure. The company disclosed in late September that Chief Financial Officer Mark Vendetti planned to retire effective March 31, 2027, and separately announced the resignation of board member John "Jay" Nichols Jr. alongside the preliminary results. Analysts responded by lowering expectations: Lake Street cut its price target to $7 from $17 while maintaining a Buy rating, citing softer pricing, unfavorable product mix, and a more gradual margin recovery. The consensus one-year target was subsequently revised down to $9.77 from $12.66.
Broader cannabis-sector weakness also contributed. Peers including Canopy Growth, Tilray, and Curaleaf traded lower during the period, and Glass House's losses were amplified by an at-the-market equity offering that raised $18 million at an average price of $8.11 per share—well above where the stock subsequently traded.
Performance Drivers Over the Past Quarter
Over the past quarter, GLAS has been in a persistent downtrend driven by the same core issue: wholesale cannabis prices in California are falling faster than Glass House can cut its production costs. Even as the company delivered record output and steadily lowered cost per pound, its average selling price and gross margin contracted, leaving investors questioning whether scale can ultimately translate into profitability and positive cash flow.
The broader narrative also shifted. The company's NYSE uplisting in mid-2026 and progress toward medical cannabis rescheduling to Schedule III initially supported the stock, but disappointing second-quarter results—including a revenue miss and a swing to a net loss—eroded confidence. Subsequent deconsolidation of the retail business, management turnover, and repeated equity dilution reinforced a cautious outlook for a still-unprofitable grower operating in a weak pricing environment.
GLAS Stock Forecast Drivers: What Investors Should Watch Next
Looking ahead, investors are likely to focus on whether wholesale cannabis pricing stabilizes and whether gross margin can recover as the trim-heavy sales mix normalizes. The company has reaffirmed full-year 2026 production guidance of approximately one million pounds and its $95-per-pound long-term cost target, so confirmation of continued cost reductions and improving unit economics will be central to the narrative.
Additional factors to monitor include the company's upcoming earnings and any updates on leadership succession following the CFO's planned retirement, the progress of its DEA registration and export applications, and developments in U.S. federal cannabis policy that could unlock interstate or international sales. Balance-sheet health, the pace of any further equity issuance, and broader California wholesale pricing trends will also shape sentiment. These considerations are informational and do not constitute financial advice.
Using Tickeron’s Trending AI Robots for Additional Context
In my own research process, I often turn to Tickeron’s Trending AI Robots page to see which automated strategies are gaining traction across the market. The section highlights a curated selection of AI-driven bots that monitor thousands of tickers and generate signals based on different timeframes and approaches. It gives a quick way to compare options without sifting through every available tool, which can help supplement manual analysis when evaluating names like GLAS.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GLAS's Stochastic Oscillator sits in oversold zone for 1 day
Be on the lookout for a price bounce soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Moving Average Convergence Divergence (MACD) for GLAS just turned positive on October 28, 2026. Looking at past instances where GLAS's MACD turned positive, the stock continued to rise in 27 of 36 cases over the following month. The odds of a continued upward trend are 75%.
GLAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GLAS as a result. In 69 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLAS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for GLAS entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.699) is normal, around the industry mean (6.379). P/E Ratio (-2.737) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (3.880) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. GLAS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PharmaceuticalsGeneric
Advertisement